Decision-Making Aspects in Valve Surgery for Active Bacterial Endocarditis

1981 ◽  
pp. 108-113 ◽  
Author(s):  
R. Hetzer ◽  
N. Papagiannakis ◽  
D. Dragojevic ◽  
H. Oelert ◽  
K. Gahl ◽  
...  
2001 ◽  
Vol 18 (Supplement 22) ◽  
pp. 17
Author(s):  
F. Guarracino ◽  
C. Zussa ◽  
E. Polesel ◽  
D. Penzo ◽  
D. De Cosmo ◽  
...  

2014 ◽  
Vol 2014 (nov19 1) ◽  
pp. bcr2014011488-bcr2014011488 ◽  
Author(s):  
T. R. Ladner ◽  
B. J. Davis ◽  
L. He ◽  
H. S. Kirshner ◽  
M. T. Froehler ◽  
...  

Author(s):  
Jeffrey S. Martin ◽  
R. Duane Davis ◽  
Donald D. Glower

Background Patient demand for less invasive surgery and interest in avoiding sternotomy has led to the increased use of the minithoracotomy for mitral valve surgery. Although the feasibility of this approach has been established, few data are available regarding intermediate-term results. Methods A total of 505 consecutive minithoracotomy mitral valve procedures performed between 1996 and 2004 were analyzed. Procedures were mitral replacement (191/505, 38%) and repair (314/505, 62%). Concomitant cardiac procedures were performed in 78 cases (13%) (maze 36, tricuspid 29, atrial septal defect/patent foramen ovale 13) and reoperation in 92 cases (18%). Arterial cannulation was ascending aorta in 403 cases (80%), femoral in 101 cases (20%), and axillary in 1 case (< 1%). An endoluminal aortic clamp was used in 406 cases (80%), an external clamp was used in 19 cases (4%), and 80 procedures (16%) were performed with ventricular fibrillation. Robotic assistance was used in 12 cases (2%). Results Mean patient age was 58.7 years (range 18–90 years). Median follow-up was 3.1 years. Operative mortality was 4 of 505 cases (<1%). Major complications included stroke in 7 cases (1%) and reoperation for bleeding in 18 cases (4%); there were no cases of mediastinitis. Late complications included chronic aortic dissection in 1 case (<1%) and mitral reoperation in 13 cases (3%) (subacute bacterial endocarditis 6, failed repair 2, other 5). Five-year survival was (83% ± 2%) and freedom from mitral reoperation was (96% ± 1%). Follow-up echocardiograms were available in 246 of 314 cases (78%) mitral repairs and mean mitral regurgitation grade was 1 ± 1. Mitral regurgitation was grade 3–4+ in 14 of 246 cases (6%) (subacute bacterial endocarditis 4, low ejection fraction 5, other 5). Five-year freedom from 3–4+ mitral regurgitation was 89% ± 3%. Conclusions Mitral valve surgery via minithoracotomy can be performed safely with a low perioperative complication rate. A durable technical result and excellent long-term survival can be expected.


Author(s):  
Jan-Philipp Minol ◽  
Vanessa Dimitrova ◽  
Georgi Petrov ◽  
Robert Langner ◽  
Udo Boeken ◽  
...  

Abstract Background With this study we aimed to analyze if the separate consideration of body mass index (BMI) could provide any superior predictive values compared with the established risk scores in isolated minimally invasive mitral valve surgery (MIMVS). This might facilitate future therapeutic decision-making, e.g., regarding the question surgery versus transcatheter mitral valve repair (TMVr). Methods We assessed the relevance of BMI in non-underweight patients who underwent isolated MIMVS. The risk predictive potential of BMI for mortality and several postoperative adverse events was assessed in 429 consecutive patients. This predictive potential was compared with that of European System for Cardiac Outcome Risk Evaluation II (EuroSCORE II) and the Society of Thoracic Surgeons score (STS score) using a comparative receiver operating characteristic curve analysis. Results BMI was a significant numeric predictor of wound healing disorders (p = 0.001) and proved to be significantly superior in case of this postoperative adverse event compared with the EuroSCORE II (p = 0.040) and STS score (p = 0.015). Except for this, the predictive potential of BMI was significantly inferior compared with that of the EuroSCORE II and STS score for several end points, including 30-day (p = 0.029 and p = 0.006) and 1-year (p = 0.012 and p = 0.001) mortality. Conclusion Therefore, we suggest that, in the course of decision-making regarding the right treatment modality for non-underweight patients with isolated mitral valve regurgitation, the sole factor of BMI should not be given a predominant weight.


2017 ◽  
Vol 31 (5) ◽  
pp. 1728-1732 ◽  
Author(s):  
Rex Joseph Morais ◽  
Balakrishnan Ashokka ◽  
Suresh Paranjothy ◽  
Chiang Siau ◽  
Lian Kah Ti

Endocarditis prophylaxis 222Most congenital heart disease patients have a lifelong risk of bacterial endocarditis (Table 18.1) and hence must be educated regarding: • Symptoms that may indicate endocarditis and when to seek expert advice.• Dental health, good oral hygiene, regular brushing, flossing, and need for regular dental check-ups—good dental hygiene and a recent dental check up must be ensured prior to valve surgery or catheter interventions involving device placement....


Sign in / Sign up

Export Citation Format

Share Document